Catalyst Wire Dossier Catalyst Wire Dossier

Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

inactivated influenza vaccine with MF59C.1 adjuvant · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010, covering 2016-01-27 to 2016-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 [Phase 2]

See pricing